Hepatitis Delta: Increasing Awareness and Treatment Competencies Enduring Material

This Enduring Material CME activity is focused on disease risk factors, progression, screening, surveillance and prevention of Delta Hepatitis. One of the key audiences will be at risk and underserved populations. We will target HCP's in community clinics, VA medical centers, community hospitals and clinician training programs.

Welcome to On-line version of the "Hepatitis Delta: Increasing Awareness and Treatment Competencies." The content represents the most up-to-date information on the diagnostic approaches and effective treatment therapies for Delta Hepatitis.

This course consists of one module offering 1.0 credit hour. During the course you will watch and listen to a video presentation.
 When you have viewed the presentation, you will be directed to take the required CME quiz, evaluate the seminar, and claim your Continuing Education credits.

Target Audience

This activity is focused on the educational needs of physicians, advanced-practice clinicians and others who care for patients who have contracted or at-risk for developing viral hepatitis. They can be found in hospitals, academic medical centers, private practice and community-based health centers and clinics.

Joint Provider Statement
 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and SC Liver Research Consortium. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
 The University of Louisville School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-22-1300. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Course Instructions 
This online CME activity has been developed by the University of Louisville School of Medicine Continuing Medical Office. This course consists of one module offering 1.0 credit hour. During the course you will watch and listen to a video presentation.

  • You will have to register and create a user profile before you are able to view the material.
  • Once you have finished viewing the material you can either close the presentation window or select the CME Publisher Portal window at the top of the screen to continue with your post-test, evaluation, and generation of your CME certificate.
  • If you are not able to complete a module in one sitting you will be able to re-access the material once you have registered for the course. CLICK HERE on the module registration link and sign in, then Click Registration History from the menu at the left of the page to continue the activity.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Paul J. Pockros, MD - Course Director, Planner; Consulting: AbbVie, lntercept, Antios, Gilead, Durect; Non-CME Services: Intercept; Contracted Research: lntercept, Gilead; Stocks/Stock Options: Novo
Howard J. Horwitz, MPH
- Course Coordinator, Planner; has no relevant financial relationships to disclose.
Robert G. Gish, MD
- Planner, Faculty: Consulting Fees: AbbVie, Abbott, Altimunne, Antios, BMS, Dynavax, Eiger, Eisai, Enyo, Genentech, Genlantis, Gerson Lehrman Group, Gilead, Helios, HepaTX, HepQuant, Intercept, Janssen, Merck, Pfizer, Venatorx; Advisory Board Fees: AbbVie, Antios, Eiger, Enyo, Gilead, HepQuant, Intercept, Janssen, Merck, Prodigy; Stock Dividends: RiboSciences, CoCrystal
Kirti Shetty, MD
- Planner, Faculty: Research Grant Funding: Glycogen
Soon Bahrami, MD - Content Reviewer; has no relevant financial relationships to disclose.
Tracy Ander, DO
- Content Reviewer; has no relevant financial relationships to disclose.
The University of Louisville CME & PD Advisory Board and Office Staff
have nothing to disclose with the following Board Member exceptions: Sathya Krishnasamy, MD -  Novo Nordisk, Kowa (Grant Funding);  Ashlee Bergin, MD – Oraganon (Speaking);  Michael Sowell, MD – Amgen, Abbvie, Biohaven, Teva, Lundbeck (Speaking); Rainer Lenhardt, MD - CSL, Behring (Speaking).

Hardware & Software Requirements
High speed internet connection
Browser: Google Chrome is recommended

Original Release & Termination Dates
Course Originally Released On: 12/22/2022
Date of Most Recent Review: 12/4/2022
Course Termination Date: 12/22/2024

Special Services
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact Howard Horwitz. Continuing Medical Education & Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Provider Contact Information
If you need technical support or have questions about the course, please e-mail us at cmepd@louisville.edu

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

The University of Louisville has obtained permission to use the content in this educational activity.

Disclosure of Support from Ineligible Companies
This Internet Activity Enduring Material is Supported by educational grants from Gilead Sciences and Eiger Biopharmaceuticals.

Course Learning Objectives
As a result of participating in this activity, participants should be able to:
Articulate the key elements in the growth in incidence of Delta Hepatitis.
• Explain how and why HBV infected individuals are at risk for HDV.
• Discuss how HDV infection has spread throughout the world and what impact it is having on individuals in the United States.
• Prepare your practice to screen patients and increase sensitivity to populations at risk.
• Increase awareness of current and emerging therapies for Delta Hepatitis.
• Evaluate the benefits and potential risk of HDV therapies.
• Develop patient and staff education modules to reduce hepatitis outbreaks and improve awareness of prevention methods.
• Translate the lessons of clinical cases to improve you diagnostic and treatment skills.
• Drive down the frequency of viral hepatitis in your practice an in your community.


There is no fee to participate in this CME course.
If you exit the activity before completion please select CLICK HERE in the registration option above then login and Click Registration History from the menu at the left of the page to continue the activity.

Content Questions and Comments
All participants are invited to submit their questions or comments about the content or cases in the presentations to
Questions will be routed to the faculty expert for reply and each will be answered within 48 hours of receipt.

This Course is Jointly Provided By